Corsight’s Upcoming DNA to FACE: 'Terrifying' Warns Privacy Expert

By Donald Maye, Published Jan 31, 2022, 07:52am EST (Info+)

Corsight plans to release a new product that combines DNA and face recognition technology and could have significant law enforcement and privacy implications.

IPVM Image

In this report, we examine Corsight’s product roadmap for "DNA to FACE," presented at the 2021 Imperial Capital Investors Conference, possible use cases for the technology, and warnings from a privacy expert.

IPVM collaborated with MIT Technology Review on this report, see the MIT Technology Review article: This company says it’s developing a system that can recognize your face from just your DNA

Corsight’s ******* - *** ** **** *********

** ******** ****, **** ******** * presentation ** ********'* ***,****** *****, *** *** ** ******** ***********,**** *****, ** *** ******** ******* ********* Conference ** *** ****.

********'* *** ******* *******, ***** *****, included ***** ********: "***** ** ****," "DNA ** ****," *** "********".

IPVM Image

** *** *****, ******** ********* "*** to ****" **:

********** * ******** ******* ** ********* genetic ******** ********* ** * *** sample

***** ** **** ************, **** *** unaware ** * ******* ********** ** commercialize * **** *********** ******* ********** with * *** ******.

******** *** *** ******* ******* ** how "***** ** ****" ***** ****. The *******'* *********** ** "********" ** more ******** ***** ** **** ***********. IPVM********** ************ ******** *** *** ***********.

"Company ************" - ******** ****** ** ******

**** ***** ******** ***** "*** ** FACE" *** *** ******** ***. ***** replied ** **** ***, ****** *************** concerns, ******** ** ******* "*** ** FACE" *******. *******, *** *** ********* that ******** ******* ** ****** *** product.

** *** *** ******** **** *** press ** *** ****** ** *** details ** **** ** *** ***** arecompany ************. We will release information once *** ****** ** *********.

Privacy ******: ********** "**********"

IPVM Image

**** *** *** ********** ****** ***** with ******* ************ *** ****,******* ** *************** ********** ********* *******. **** ****** ******** ** ********* bias *** ******** *** ***** ********** with ********* *** **** **** *********** technology, ******* *** *********** '**********':

*** **** **** ***'** *** ***** try ** ******* *** *** ************ isreally ********** because not just because of the obvious potential drive of bias ********, *** **** *** ******** *** ***** ****.

**** **** ********** *** *********** ** such **********:

*** **** ***'** ***** ** **** to *** * ****** *********** ****** against * ********* ***** *** **** anything *********** ******** ******* ** ** is **** *staggering *****, ** **** ***** *************.

*** ** *** **** **** ***'** gonna ** **** ** ****** ********* with *** ***** ** *********** *** fidelity, ****'* ********* ** *** * face ***** ****** ** **,that's ************, **** ** *************.

Possible *** ***** *** *** ** ****

***** ******** ******** ** ********* ** specific *** *****, *** **** ***** stated ****** ********’* ************ **** *** progression ** ** *** ******* ******** have **** **** ********** **********.

*** ** *** ********* *** **** for ********* *** *** ************ ** law *********** *** ******** ******** ** crime ******. *** *******, ******** * composite ***** ** * ******* **** DNA ***** ** * ***** ***** would ****** ************* ** ***** *** image ** ******** ***** ********* ** show ** *********. ************, **** ********** could **** ** **** ** ******* cold ***** ********* *** ********.

*******

******** ***** *********** ********** ** *** commercialization ** "*** ** ****." ******* the ******** *** ***** *** *** clear *** *** ******** ** ********'* technology ** *******. ** *** ******* is ********** ********, ** ******** *******, "DNA ** ****" **** **** **** scrutiny **** *** ***********/***** *** *******-****** perspectives.

Comments (7)

***** * ** *** **** **** Corsight's ********** *** **** *** ******, this **** ******* *******'* ***** ****** ** ****** aggressive ******. *** *******, *** *** *** circle ***** ****** * ******* ****** recognition ***** ** *** *******'* ********* below:

IPVM Image

**** ***** ******** ** **, **** genuinely ******* **** *** ******** *** accurately ** ***** ******, **** ***** where **** ********* * **** ("*** Williams") ** * "*** ********** ******", with * **+ ***** ***** ** View, ** * ****** ******* * mask ** * *** ***** ** the ******.

* ***** ********* **** **** *** claim ***********, ** ***** ** ***** to ***** **** ** ** ******** conference *** *'* ** ********* ***** this ******** * ********** ********** ******** for ****.

Agree: 3
Disagree
Informative: 3
Unhelpful
Funny

* ********** **** **** ********* **** this, **** *** ******* ****** ****** about *** ******** **** **, **** start ** ****** *** ****. **** is *** * **** **** ********* should ****** * ******* **** ** rights **** ******** * ***** ** privacy *** ** ** ********* **** the ********.

Agree: 4
Disagree: 1
Informative
Unhelpful
Funny

**** ** *** ******* ** **** tech ** *********** ***** ********** ******'* *****:

********’* **** ** *** ******** ***. Human *********, * “********-*****, ****** ************” company ******* ** ******* ****** *********** Craig ****** ******** *********, ******* ** ******** *** ** ******* ******* ****. *** ********** ****** ******** then ***********, *******, **** ********. * ****** ******** ** ***** Longevity **** *** ******* ***’* **** a ****** *** ** * ***** using * ******, *** ***** ******, chief ******* ******* ** *** ********* platform **********,********* * ******** ****** *** ***** flaws** *** ********.

**** ******** ********* ** ****** **************:****** *********** **** *** ***** ****-**-*** classifiers********* **** * ***********:

IPVM Image

**** ******** ********* ** ****:************** ** *********** ** ***** ********** using *****-****** ********** ********* **** ****** **** ** ******, skin ***** *** *** ***** **** predicted **** **** ********. *******, **** complex ****** **** **** ********.

** ********* *********** ****** ****** **** as *** *****, **** *****, *** sex ** **** ********. *******, *** complex ******, *** ****** ********* **** small ********* ** *** ******** ********** variation.

Agree
Disagree
Informative: 5
Unhelpful
Funny

******** ********* "*** ** ****" **: "Constructs * ********profile by analyzing genetic material collected in a DNA sample" [empasis added]

**** ******* ** ** * **** bad **** ** ********* ******* *** much *********** ******** ** ** **********'* face *** **** ***** ** *** from ***? **** *** ***** ********, it ******* **** ******.

** ********* *********** ****** ****** **** as *** *****, **** *****, *** sex ** **** ********. *******, *** complex ******, *** ****** ********* **** small ********* ** *** ******** ********** variation.

****'* *** ******** ***** ** ****** facial *********** ** ** ** ******** used, *.*., *********** * ******** ****, not ******** ** **** ***** *** sex.

Agree
Disagree
Informative
Unhelpful
Funny

* **** *********** ******* *****.

***** * ***** **** ** ********* to ** **** ** ******** *******, specific, ******* *** ******** ************** **** DNA, ***, **** *** **** ****** for ******* ****** ** **** ***, to * ******, ************ ************. *** the **** **** *** ***** *** DNA ** *********** **** * **** would **** ****? **** ** **** aspects ** *** *** ******** ****** in * ***** *** *****? **** sounds **** *** ***** **** ** pseudo-science *******.

Agree
Disagree
Informative: 1
Unhelpful
Funny

**** **** **** ****** ********* ** this. ** ********* ******* ** ** implausible ******** ******** (**** **** ** 23andme *********** *** ** *** - they ****** ******* ********* ****** ** percent ********** ** **** * ***** most ****** ******* ********, **** ****** they **** **** ** ******* *** the ** *******). *** *** ***** thing ** **** **** ***** *** get ******** *** * ********* ******** interest, ** *** **** *** **** with ******* ***** ******* *********, **** as *** *** ********** ******** ****** and ********* ****** **** * *****!

Agree
Disagree
Informative
Unhelpful
Funny

****** * ***** ** *** **** could ** ****, * ***** ****** you ***** ******* *** **** ** process. ***** *** ** **** **** undeniable ******** *** ******** *** ********* confirmation. ** ************* ** ******* *** from * ***** ***** *** ***** perhaps ** * ******* **** ** in * *** ******** *** ********* of *** ******* (******** *** **** access ** **** *********) *** ******* a ****** **** ***** ** **** they ***** **** **** ***** ** nearest ** ********* *********, ********** ** several *** ******* (****/*** ******, ***,***) are ******* ******** ******* *** ******* DNA *******. ** *****'* *********** ********* accuracy *** *** ****, *** ** is * ***** ** ********* ** the *************. *** *********** ** **** capabilities ***** ****** ** ******** *** one ** *** **** ***** ** the ******* ******...

Agree
Disagree
Informative
Unhelpful
Funny
Login to read this IPVM report.
Why do I need to log in?
IPVM conducts reporting, tutorials and software funded by subscriber's payments enabling us to offer the most independent, accurate and in-depth information.
Loading Related Reports